Alebund
Shanghai, CN · 3 known investors
Alebund Pharmaceuticals develops innovative treatments for kidney diseases, with a pipeline covering chronic kidney conditions such as diabetic nephropathy, IgA nephropathy, FSGS, and ADPKD, as well as end-stage renal disease complications like hyperphosphatemia and anemia. The company operates across drug research, manufacturing, and commercialization for kidney disease patients globally.
BiotechDigital Health
Investors · 3
Frequently asked questions
- What does Alebund do?
- Alebund Pharmaceuticals develops innovative treatments for kidney diseases, with a pipeline covering chronic kidney conditions such as diabetic nephropathy, IgA nephropathy, FSGS, and ADPKD, as well as end-stage renal disease complications like hyperphosphatemia and anemia. The company operates across drug research, manufacturing, and commercialization for kidney disease patients globally.
- Who are Alebund's investors?
- Alebund's investors include LAV, Lilly Asia Ventures, Quan Capital.
- Where is Alebund headquartered?
- Alebund is headquartered in Shanghai, CN.